Manulife (Manufacturers Life Insurance)’s Zentalis Pharmaceuticals ZNTL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-22,874
| Closed | -$36.4K | – | 3014 |
|
2025
Q1 | $36.4K | Sell |
22,874
-105,334
| -82% | -$167K | ﹤0.01% | 2858 |
|
2024
Q4 | $388K | Buy |
128,208
+84
| +0.1% | +$255 | ﹤0.01% | 2354 |
|
2024
Q3 | $471K | Sell |
128,124
-1,005
| -0.8% | -$3.7K | ﹤0.01% | 2318 |
|
2024
Q2 | $528K | Sell |
129,129
-2,686
| -2% | -$11K | ﹤0.01% | 2195 |
|
2024
Q1 | $2.08M | Buy |
131,815
+14,921
| +13% | +$235K | ﹤0.01% | 1503 |
|
2023
Q4 | $1.77M | Buy |
116,894
+26,491
| +29% | +$401K | ﹤0.01% | 1510 |
|
2023
Q3 | $1.81M | Buy |
90,403
+8,783
| +11% | +$176K | ﹤0.01% | 1472 |
|
2023
Q2 | $2.3M | Buy |
81,620
+18,501
| +29% | +$522K | ﹤0.01% | 1375 |
|
2023
Q1 | $1.09M | Buy |
63,119
+33
| +0.1% | +$568 | ﹤0.01% | 1595 |
|
2022
Q4 | $1.19M | Buy |
63,086
+3,526
| +6% | +$66.7K | ﹤0.01% | 1537 |
|
2022
Q3 | $1.28M | Sell |
59,560
-302
| -0.5% | -$6.5K | ﹤0.01% | 1505 |
|
2022
Q2 | $1.64M | Sell |
59,862
-9,951
| -14% | -$273K | ﹤0.01% | 1471 |
|
2022
Q1 | $3.19M | Buy |
69,813
+51,392
| +279% | +$2.35M | ﹤0.01% | 1384 |
|
2021
Q4 | $1.53K | Buy |
18,421
+181
| +1% | +$15 | ﹤0.01% | 1607 |
|
2021
Q3 | $1.22M | Sell |
18,240
-325
| -2% | -$21.7K | ﹤0.01% | 1718 |
|
2021
Q2 | $988K | Buy |
18,565
+2,399
| +15% | +$128K | ﹤0.01% | 2003 |
|
2021
Q1 | $701K | Sell |
16,166
-796
| -5% | -$34.5K | ﹤0.01% | 2080 |
|
2020
Q4 | $881K | Buy |
16,962
+10,625
| +168% | +$552K | ﹤0.01% | 1892 |
|
2020
Q3 | $207K | Buy |
6,337
+402
| +7% | +$13.1K | ﹤0.01% | 2542 |
|
2020
Q2 | $270K | Buy |
+5,935
| New | +$270K | ﹤0.01% | 2321 |
|